World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Global Blood Therapeutics

    World Rank (Jan-05-2024)
    6,607
    World Rank (Jul-30-2023)
    6,607
    World Rank (Dec-25-2022)
    6,607
    World Rank (Jan-07-2022)
    6,607
    Market Cap (Jan-07-2022)
    1.85 Billion USD
    Annual Revenue in USD
    194 Million USD
    Annual Net Income in USD
    -303 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    Global Blood Therapeutics is a Biopharmaceutical Company. It is to transform the treatment of sickle cell disease and an overlooked rare condition and help address the urgent needs of the community. The company medicine is the first treatment approved by the FDA to target an underlying cause of SCD. The headquarters is in USA.

    Company Website
    GLOBAL BLOOD THERAPEUTICS INC

  3. Constellation Pharmaceuticals

    World Rank (Jan-05-2024)
    6,721
    World Rank (Jul-30-2023)
    6,721
    World Rank (Dec-25-2022)
    6,721
    World Rank (Jan-07-2022)
    6,721
    Annual Revenue in USD
    8,614 Million USD
    Annual Net Income in USD
    1,998 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Profile
    Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.
    Company Website
    CONSTELLATION PHARMACEUTICALS

  4. Kymera Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,735
    Market Cap (Jan-05-2024)
    1.510 Billion USD
    World Rank (Jul-30-2023)
    7,820
    Market Cap (Jul-30-2023)
    1.208 Billion USD
    World Rank (Dec-25-2022)
    6,679
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,018
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    47 Million USD
    Annual Operating Income in USD
    -154 Million USD
    Annual Net Income in USD
    -154 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kymera is a Biopharmaceutical company. It is a developing novel protein degrader therapeutics to treat disease in powerful new ways which harness the body's natural protein degradation system to selectively degrade disease causing proteins with the goal of completely removing them from the body. The company annual revenue is 10.4 million USD and 67 employees as on 2019. The headquarters is in USA.
    Company Website
    KYMERA THERAPEUTICS, INC.

  5. Keymed Biosciences Inc.

    World Rank (Jan-05-2024)
    6,778
    Market Cap (Jan-05-2024)
    1.493 Billion USD
    World Rank (Jul-30-2023)
    5,733
    Market Cap (Jul-30-2023)
    2.008 Billion USD
    World Rank (Dec-25-2022)
    5,744
    Market Cap (Dec-25-2022)
    1.837 Billion USD
    World Rank (Jan-07-2022)
    9,089
    Market Cap (Jan-07-2022)
    1.06 Billion USD
    Headquarters Country
    China
    Company Website
    KEYMED BIOSCIENCES INC.

  6. Arcus Biosciences

    World Rank (Jan-05-2024)
    6,836
    Market Cap (Jan-05-2024)
    1.477 Billion USD
    World Rank (Jul-30-2023)
    7,002
    Market Cap (Jul-30-2023)
    1.455 Billion USD
    World Rank (Dec-25-2022)
    6,609
    Market Cap (Dec-25-2022)
    1.478 Billion USD
    World Rank (Jan-07-2022)
    5,322
    Market Cap (Jan-07-2022)
    2.63 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -280 Million USD
    Annual Net Income in USD
    -267 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Arcus is a Biopharmaceutical company aiming to bring together scientists, physicians and advisors to focus on developing best in class cancer therapies. The company annual revenue is 77.8 million USD and 108 employees as on 2019. The headquarters is in USA.
    Company Website
    ARCUS BIOSCIENCES

  7. Keros Therapeutics Inc.

    World Rank (Jan-05-2024)
    6,873
    Market Cap (Jan-05-2024)
    1.464 Billion USD
    World Rank (Jul-30-2023)
    7,679
    Market Cap (Jul-30-2023)
    1.242 Billion USD
    World Rank (Dec-25-2022)
    7,230
    Market Cap (Dec-25-2022)
    1.286 Billion USD
    World Rank (Jan-07-2022)
    8,347
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -107 Million USD
    Annual Net Income in USD
    -104 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Keros Therapeutics is a Clinical Stage Biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics by leveraging deep understanding of specifically hematopoiesis and musculoskeletal systems. The company annual revenue is 10 million USD and 23 employees as on 2019. The headquarters is in USA.
    Company Website
    KEROS THERAPEUTICS, INC.

  8. Meridian Bioscience

    World Rank (Jan-05-2024)
    6,902
    World Rank (Jul-30-2023)
    6,902
    Market Cap (Jul-30-2023)
    1.490 Billion USD
    World Rank (Dec-25-2022)
    6,678
    Market Cap (Dec-25-2022)
    1.455 Billion USD
    World Rank (Jan-07-2022)
    10,067
    Market Cap (Jan-07-2022)
    0.89 Billion USD
    Annual Revenue in USD
    317 Million USD
    Annual Net Income in USD
    71 Million USD
    Annual Results for Period Ending
    Sep-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 disease targets and an extensive range of specialty qPCR master mixes and molecular enzymes manufactured under ISO13485 regulations. Meridian offers diagnostic manufacturers the complete solution. The headquarters is in USA.

    Meridian Bioscience was acquired by SD Biosensor and SJL Partners in 2022.

    Company Website
    MERIDIAN BIOSCIENCE

  9. Aurisco Pharmaceutical Co. Ltd

    World Rank (Jan-05-2024)
    6,907
    Market Cap (Jan-05-2024)
    1.450 Billion USD
    World Rank (Jul-30-2023)
    7,343
    Market Cap (Jul-30-2023)
    1.341 Billion USD
    World Rank (Dec-25-2022)
    6,757
    Market Cap (Dec-25-2022)
    1.425 Billion USD
    World Rank (Jan-07-2022)
    8,012
    Market Cap (Jan-07-2022)
    1.33 Billion USD
    Headquarters Country
    China
    Company Website
    AURISCO PHARMACEUTICAL CO.,LTD.

  10. Chengzhi Shareholding

    World Rank (Jan-05-2024)
    6,910
    Market Cap (Jan-05-2024)
    1.449 Billion USD
    World Rank (Jul-30-2023)
    7,189
    Market Cap (Jul-30-2023)
    1.396 Billion USD
    World Rank (Dec-25-2022)
    6,564
    Market Cap (Dec-25-2022)
    1.498 Billion USD
    World Rank (Jan-07-2022)
    4,826
    Market Cap (Jan-07-2022)
    3.02 Billion USD
    Annual Revenue in USD
    1,773 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    CHENGZHI SHAREHOLDING

Share